This compound is a protected glutamic acid derivative featuring benzyl ester and benzyloxycarbonyl (Cbz) protective groups. It serves as a key building block in solid-phase peptide synthesis, enabling the incorporation of glutamic acid residues while preventing unwanted side reactions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 3705-42-8
N-Carbobenzoxy-D-glutamic acid
pharmaceutical intermediate
N-Cbz-L-glutamic acid
research compound
N-[(Phenylmethoxy)carbonyl]-L-glutamic acid tert-butyl ester
pharmaceutical intermediate
Boc-D-glutamic acid 1-benzyl ester
pharmaceutical intermediate
L-tert-Leucine methyl ester hydrochloride
pharmaceutical intermediate
Boc-L-glutamic acid 1-methyl ester
pharmaceutical intermediate
L-Aspartic acid di-tert-butyl ester hydrochloride
pharmaceutical intermediate
Benzyl L-leucinate--hydrogen chloride (1/1)
pharmaceutical intermediate
(4S)-5-oxo-5-phenylmethoxy-4-(phenylmethoxycarbonylamino)pentanoic acid
VWHKODOUMSMUAF-KRWDZBQOSA-N
C1=CC=C(C=C1)COC(=O)[C@H](CCC(=O)O)NC(=O)OCC2=CC=CC=C2